Privi Speciality Chemicals Limited

NSEI:PRIVISCL 株式レポート

時価総額:₹71.8b

Privi Speciality Chemicals マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Mahesh Babani

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間7.7yrs
CEOの所有権13.5%
経営陣の平均在職期間4.4yrs
取締役会の平均在任期間6yrs

経営陣の近況

Recent updates

These 4 Measures Indicate That Privi Speciality Chemicals (NSE:PRIVISCL) Is Using Debt Extensively

Nov 17
These 4 Measures Indicate That Privi Speciality Chemicals (NSE:PRIVISCL) Is Using Debt Extensively

Some Confidence Is Lacking In Privi Speciality Chemicals Limited's (NSE:PRIVISCL) P/S

Oct 14
Some Confidence Is Lacking In Privi Speciality Chemicals Limited's (NSE:PRIVISCL) P/S

Privi Speciality Chemicals Limited (NSE:PRIVISCL) Looks Just Right With A 28% Price Jump

Jun 25
Privi Speciality Chemicals Limited (NSE:PRIVISCL) Looks Just Right With A 28% Price Jump

Privi Speciality Chemicals (NSE:PRIVISCL) Takes On Some Risk With Its Use Of Debt

Jun 04
Privi Speciality Chemicals (NSE:PRIVISCL) Takes On Some Risk With Its Use Of Debt

What Privi Speciality Chemicals Limited's (NSE:PRIVISCL) 25% Share Price Gain Is Not Telling You

Apr 30
What Privi Speciality Chemicals Limited's (NSE:PRIVISCL) 25% Share Price Gain Is Not Telling You

Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?

Sep 05
Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Privi Speciality Chemicals (NSE:PRIVISCL) Is Using Debt Extensively

Mar 10
These 4 Measures Indicate That Privi Speciality Chemicals (NSE:PRIVISCL) Is Using Debt Extensively

Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?

Sep 21
Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?

Privi Speciality Chemicals (NSE:PRIVISCL) Has A Somewhat Strained Balance Sheet

Jun 21
Privi Speciality Chemicals (NSE:PRIVISCL) Has A Somewhat Strained Balance Sheet

Here's Why Privi Speciality Chemicals (NSE:PRIVISCL) Has A Meaningful Debt Burden

Feb 15
Here's Why Privi Speciality Chemicals (NSE:PRIVISCL) Has A Meaningful Debt Burden

Is Privi Speciality Chemicals (NSE:PRIVISCL) A Risky Investment?

May 24
Is Privi Speciality Chemicals (NSE:PRIVISCL) A Risky Investment?

Trade Alert: The Independent Director Of Privi Speciality Chemicals Limited (NSE:PRIVISCL), Anurag Surana, Has Just Spent ₹9.9m Buying 200% More Shares

Feb 26
Trade Alert: The Independent Director Of Privi Speciality Chemicals Limited (NSE:PRIVISCL), Anurag Surana, Has Just Spent ₹9.9m Buying 200% More Shares

Shareholders of Privi Speciality Chemicals (NSE:PRIVISCL) Must Be Delighted With Their 359% Total Return

Feb 24
Shareholders of Privi Speciality Chemicals (NSE:PRIVISCL) Must Be Delighted With Their 359% Total Return

Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?

Jan 31
Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?

What To Know Before Buying Privi Speciality Chemicals Limited (NSE:PRIVISCL) For Its Dividend

Jan 16
What To Know Before Buying Privi Speciality Chemicals Limited (NSE:PRIVISCL) For Its Dividend

Privi Speciality Chemicals Limited's (NSE:PRIVISCL) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 03
Privi Speciality Chemicals Limited's (NSE:PRIVISCL) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Is Privi Speciality Chemicals Limited's (NSE:PRIVISCL) Shareholder Ownership Skewed Towards Insiders?

Dec 21
Is Privi Speciality Chemicals Limited's (NSE:PRIVISCL) Shareholder Ownership Skewed Towards Insiders?

Read This Before Selling Privi Speciality Chemicals Limited (NSE:PRIVISCL) Shares

Dec 08
Read This Before Selling Privi Speciality Chemicals Limited (NSE:PRIVISCL) Shares

If You Had Bought Privi Speciality Chemicals (NSE:PRIVISCL) Shares Five Years Ago You'd Have Earned 124% Returns

Nov 25
If You Had Bought Privi Speciality Chemicals (NSE:PRIVISCL) Shares Five Years Ago You'd Have Earned 124% Returns

Are Privi Speciality Chemicals's (NSE:PRIVISCL) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Nov 12
Are Privi Speciality Chemicals's (NSE:PRIVISCL) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Is It Smart To Buy Privi Speciality Chemicals Limited (NSE:PRIVISCL) Before It Goes Ex-Dividend?

Oct 21
Is It Smart To Buy Privi Speciality Chemicals Limited (NSE:PRIVISCL) Before It Goes Ex-Dividend?

Privi Speciality Chemicals Limited (NSE:FAIRCHEM) Is An Attractive Dividend Stock - Here's Why

Oct 12
Privi Speciality Chemicals Limited (NSE:FAIRCHEM) Is An Attractive Dividend Stock - Here's Why

Does Fairchem Speciality (NSE:FAIRCHEM) Have A Healthy Balance Sheet?

Sep 27
Does Fairchem Speciality (NSE:FAIRCHEM) Have A Healthy Balance Sheet?

A Piece Of The Puzzle Missing From Fairchem Speciality Limited's (NSE:FAIRCHEM) Share Price

Sep 14
A Piece Of The Puzzle Missing From Fairchem Speciality Limited's (NSE:FAIRCHEM) Share Price

The Independent Director of Fairchem Speciality Limited (NSE:FAIRCHEM), Anurag Surana, Just Bought 400% More Shares

Aug 28
The Independent Director of Fairchem Speciality Limited (NSE:FAIRCHEM), Anurag Surana, Just Bought 400% More Shares

Should We Be Excited About The Trends Of Returns At Fairchem Speciality (NSE:FAIRCHEM)?

Aug 18
Should We Be Excited About The Trends Of Returns At Fairchem Speciality (NSE:FAIRCHEM)?

Is Fairchem Speciality Limited's (NSE:FAIRCHEM) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Aug 03
Is Fairchem Speciality Limited's (NSE:FAIRCHEM) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Did Fairchem Speciality Limited (NSE:FAIRCHEM) Insiders Buy Up More Shares?

Jul 19
Did Fairchem Speciality Limited (NSE:FAIRCHEM) Insiders Buy Up More Shares?

Is Fairchem Speciality's (NSE:FAIRCHEM) Share Price Gain Of 120% Well Earned?

Jul 07
Is Fairchem Speciality's (NSE:FAIRCHEM) Share Price Gain Of 120% Well Earned?

Fairchem Speciality (NSE:FAIRCHEM) Is Growing Earnings But Are They A Good Guide?

Jun 25
Fairchem Speciality (NSE:FAIRCHEM) Is Growing Earnings But Are They A Good Guide?

CEO報酬分析

Privi Speciality Chemicals の収益と比較して、Mahesh Babani の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

₹1b

Jun 30 2024n/an/a

₹1b

Mar 31 2024n/an/a

₹949m

Dec 31 2023n/an/a

₹502m

Sep 30 2023n/an/a

₹271m

Jun 30 2023n/an/a

₹45m

Mar 31 2023₹60m₹60m

₹222m

Dec 31 2022n/an/a

₹658m

Sep 30 2022n/an/a

₹851m

Jun 30 2022n/an/a

₹905m

Mar 31 2022₹60m₹60m

₹974m

Dec 31 2021n/an/a

₹1b

Sep 30 2021n/an/a

₹1b

Jun 30 2021n/an/a

₹1b

Mar 31 2021₹50m₹50m

₹1b

報酬と市場: Maheshの 総報酬 がIndian市場の同規模の企業と比較して妥当かどうかを判断するにはデータが不十分です。

報酬と収益: Maheshの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Mahesh Babani (66 yo)

7.7yrs

在職期間

₹60,000,000

報酬

Mr. Mahesh Purshottambhai Babani serves as Chairman of the Board at Privi Speciality Chemicals Limited (formerly known as Fairchem Speciality Limited) since August 13, 2020. He has been Managing Director o...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Narayan Iyer
Chief Financial Officer4.4yrs₹10.44mデータなし
Bhaktavatsala Doppalapudi
Executive Director4.4yrs₹2.40m3.96%
₹ 2.8b
Mahesh Babani
MD & Chairmanno data₹60.00m13.54%
₹ 9.7b
R.S. Rajan
President4.4yrs₹20.33mデータなし
Ramesh Kathuria
Group Company Secretary & Head Legal4.4yrsデータなしデータなし
Ashwini Shah
Company Secretary & Compliance Officer2.2yrsデータなしデータなし

4.4yrs

平均在職期間

経験豊富な経営陣: PRIVISCLの経営陣は 経験豊富 であると考えられます ( 4.4年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Bhaktavatsala Doppalapudi
Executive Director7.7yrs₹2.40m3.96%
₹ 2.8b
Mahesh Babani
MD & Chairman7.7yrs₹60.00m13.54%
₹ 9.7b
Dwarko Khilnani
Independent Non-Executive Director4.4yrs₹400.00kデータなし
Anurag Surana
Independent Non-Executive Director4.4yrs₹500.00k0.051%
₹ 36.8m
Anuradha Thakur
Independent Non-Executive Woman Director4.4yrs₹500.00kデータなし
Hemang Gandhi
Independent Director7.7yrs₹150.00kデータなし

6.0yrs

平均在職期間

71yo

平均年齢

経験豊富なボード: PRIVISCLの 取締役会経験豊富 であると考えられます ( 6年の平均在任期間)。


企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2025/01/04 10:11
終値2025/01/03 00:00
収益2024/09/30
年間収益2024/03/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を例とし、非米国証券については同等の規制書式と情報源を使用

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Privi Speciality Chemicals Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4

アナリスト機関
null nullAsian Markets Securities Private Limited
Kameswari V. S. ChavaliFirstCall Research
Chintan ModiHaitong International Research Limited